Concord Drugs (BOM:538965) has received purchase orders worth approximately 147.1 million from various entities, including Tamil Nadu Medical Services Corp., Directorate General of Health Services, and Telangana State Medical Services & Infrastructure Development Corp. and other entities, according to an Indian bourse filing on Tuesday.
The orders, covering supply of pharmaceutical products over the next 45 to 60 days, exceed the company's materiality threshold, the filing said.